Peptides are getting a lot of attention. Clear, careful guidance is harder to find. Dr. Leandro Pucci, DCN, CNS, helps you understand where peptides may fit within a nutrition-first, root-cause approach to metabolic health, and where they don't.
Peptides are short chains of amino acids, the same building blocks that make up proteins. Where a protein may contain hundreds of amino acids, a peptide typically contains between two and fifty.
Your body already makes thousands of them. Many act as signaling molecules: they carry messages between cells and tissues. Insulin, which regulates blood glucose, is a peptide. So are many of the hormones that govern appetite, satiety, digestion, and tissue repair.
Because peptides work through signaling pathways the body already uses, researchers have studied them for decades as a way to support specific physiological functions. Some peptide-based medications are FDA-approved and widely prescribed. Many others are still being studied, and the quality of evidence varies considerably from one compound to the next.
Metabolic health depends on communication. Glucose regulation, insulin sensitivity, appetite signaling, fat storage, liver function, and recovery all rely on the body sending and receiving the right signals at the right time. When that communication breaks down, the result often shows up as insulin resistance, stubborn weight gain, elevated triglycerides, fatty liver, poor sleep, or slow recovery.
Peptide research focuses on many of these same signaling pathways. That is why interest has grown among people working on blood sugar, body composition, energy, and healthy aging.
Interest is not the same as evidence. Some peptides have strong human trial data. Others rely mostly on animal studies, small pilot trials, or anecdotal reports. A responsible conversation starts by separating the two.
No signaling molecule can compensate for a diet that keeps insulin chronically elevated, sleep that never fully restores, or a nervous system stuck in high alert. In my practice, peptides are never the starting point. They are one possible conversation that happens after the foundations are in place.
The foundations I assess first:
Many people find that once these are addressed, the question of peptides changes or disappears. For others, it becomes a more informed and better-timed conversation with their prescribing clinician.
The examples below are among the peptides people most often ask about in relation to metabolism. They are listed for education only, to show the range of what exists and how much the evidence differs between them. Inclusion here is not a recommendation, and I do not prescribe, dose, or supply any of them.
Peptide | Pathway | What it has been studied for | Evidence and status |
GLP-1 receptor agonists (e.g., semaglutide) | Incretin hormone signaling | Blood sugar control, appetite and satiety, weight reduction, cardiovascular risk | Strong evidence from large human trials. FDA-approved prescription medications for type 2 diabetes and weight management. |
Dual GIP/GLP-1 agonists (e.g., tirzepatide) | Incretin hormone signaling | Blood sugar control, weight reduction, sleep apnea related to obesity | Strong evidence from large human trials. FDA-approved prescription medication. |
Tesamorelin | Growth hormone-releasing hormone | Reduction of visceral (abdominal) fat; liver fat in specific populations | Human trial evidence. FDA-approved only for excess abdominal fat in HIV-associated lipodystrophy. |
CJC-1295 and ipamorelin | Growth hormone release | Growth hormone and IGF-1 levels, body composition, sleep and recovery | Limited human data. Not FDA-approved. Compounding status under federal review. |
MOTS-c | Mitochondrial signaling | Insulin sensitivity, glucose uptake in muscle, exercise capacity | Mostly animal and cell research; minimal human data. Not FDA-approved. Compounding status under federal review. |
AOD-9604 | Fragment of growth hormone | Fat metabolism and weight loss | Human trials did not show meaningful weight loss. Not FDA-approved. |
BPC-157 | Tissue repair signaling | Gut lining integrity, tissue healing | Mostly animal research; very limited human data. Not FDA-approved. Compounding status under federal review. |
Elamipretide (SS-31) | Mitochondrial membrane support | Mitochondrial energy production | FDA-approved (accelerated approval, 2025) only for Barth syndrome, a rare genetic disorder. Metabolic uses remain investigational. |
Regulatory status as of October 2026
The pattern matters more than any single entry. The peptides with the strongest metabolic evidence are FDA-approved medications prescribed by physicians. Many of the most talked-about peptides online rest on early research, and that is the gap a careful consultation helps you understand.
A consultation is a structured, evidence-focused conversation about your metabolic health and whether peptides belong in it. It is designed to help you ask better questions and make informed decisions with your medical team.
What we cover:
What a consultation does not include:
Any decision about a peptide-based treatment is made by you and a licensed prescriber. My role is to make sure that decision rests on a solid metabolic foundation and an honest reading of the evidence.
A peptide education consultation tends to be most useful if you:
If you are looking for a quick protocol or a product recommendation, this is not the right service. If you want to understand your metabolism and make careful, informed choices, it likely is.
Peptides are not a single category with a single safety profile. Risk depends on the specific compound, the dose, how long it is used, how it is taken, your medications and medical history, and the quality of the product itself.
Product quality is a real concern. Many peptides sold online are labeled "for research use only" and are not made for human use. Without pharmaceutical-grade manufacturing and third-party testing, there is no reliable way to confirm what a product contains or how pure it is.
The regulatory status of many peptides is also in flux. The FDA has been reviewing which peptides compounding pharmacies may prepare, and that guidance has shifted more than once in the past few years. What is permitted today may change.
For these reasons, I encourage a conservative approach: work with a licensed prescriber, use only properly regulated sources, get baseline labs, and plan for follow-up monitoring. A careful process protects your health and gives you a clear way to judge whether anything is working.
Peptides are small chains of amino acids that act as messengers in the body. Depending on the peptide, they may influence specific biological pathways such as appetite signaling, glucose regulation, or tissue repair. Benefits, risks, and the strength of supporting evidence vary from one peptide to the next, which is why any treatment decision belongs with a qualified, licensed clinician.
There is no single answer. Safety depends on the specific compound, your medical history and medications, the dose and duration, how it is administered, and product quality. Clinical supervision, appropriate lab testing, and ongoing monitoring are the most reliable ways to evaluate and manage risk.
Most people do not start there. Nutrition, sleep, stress, and movement shape the same metabolic pathways peptides are studied for, and they carry the strongest evidence. Many people see meaningful changes in blood sugar, energy, and body composition from these foundations alone.
No. As a Doctor of Clinical Nutrition and Certified Nutrition Specialist, I do not prescribe, sell, or administer peptides or medications. I provide education, metabolic assessment, and nutrition and lifestyle care, and I can coordinate with your physician when appropriate.
Often, yes. Baseline labs help identify metabolic patterns, flag potential concerns, and create a reference point for tracking progress. I will review any recent results you have and may suggest additional tests to discuss with your physician.
There is no universal timeline. Response depends on your health status, your goals, how consistently you follow your plan, and which interventions you and your medical team choose. We will set realistic expectations and clear markers for progress from the start.
[Insert consultation and program pricing, and whether insurance or superbills apply.] Before starting any peptide-based treatment with a prescriber, ask for an itemized estimate covering consultations, testing, medication, supplies, and follow-up visits.
If you are curious about peptides and want guidance grounded in metabolic science rather than marketing, the first step is a discovery call. We will talk through your goals, your health history, and whether a peptide education consultation or one of my programs is the right fit.
Dr. Leandro Pucci, DCN, CNS®, CKNS®, LDN · West Hollywood, CA · 323.450.7554 · info@leandropucci.com
Disclaimer: The information on this page is for educational purposes only and is not medical advice. Leandro Pucci Nutrition does not diagnose, treat, or cure any disease, and does not prescribe, sell, dispense, or administer peptides or medications. Peptide-based treatments should be considered only under the care of a licensed medical provider. Many peptides are not approved by the U.S. Food and Drug Administration, and their regulatory status may change. Always consult your physician before starting any new treatment.